{"id":"W3118386410","doi":"10.1016/j.clinre.2020.101604","title":"Vedolizumab for steroid & infliximab refractory immune checkpoint inhibitor associated colitis","year":2021,"lang":"en","type":"letter","venue":"Clinics and Research in Hepatology and Gastroenterology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Vedolizumab; Medicine; Infliximab; Colitis; Refractory (planetary science); Internal medicine; Pharmacology; Gastroenterology; Ulcerative colitis; Tumor necrosis factor alpha; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007592964,0.0006331285,0.0009582315,0.0006853646,0.002871934,0.002084816,0.000817134,0.0263621,0.005762618],"category_scores_gemma":[0.006125454,0.0004698556,0.001180972,0.000515956,0.001361764,0.001422491,0.0007517379,0.01615209,0.003098097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003368503,"about_ca_system_score_gemma":0.002309053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003766297,"about_ca_topic_score_gemma":0.008917775,"domain_scores_codex":[0.9992804,0.0001778001,0.00009183633,0.00008200804,0.0001691095,0.0001987765],"domain_scores_gemma":[0.9985191,0.0007395551,0.0001440796,0.00003891328,0.0001641529,0.0003942321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"case_report","study_design_scores_codex":[0.0004189793,0.0001635686,0.00480424,0.0002017479,0.00006603811,0.1294089,0.0002217315,0.0003933719,0.001268503,0.006289139,0.8230171,0.03374673],"study_design_scores_gemma":[0.0011286,0.0005242577,0.008866911,0.0009539794,0.0001688824,0.1176688,0.0005552283,0.003615304,0.001036579,0.01738996,0.8479899,0.0001016579],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.0051359,0.003979753,0.0003184651,0.9542271,0.01821268,0.00005718799,0.0001233277,0.00004868957,0.01789678],"genre_scores_gemma":[0.05803222,0.005253031,0.001038701,0.8302422,0.07280909,0.00009766645,0.0001762999,0.00005535944,0.03229555],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0263621,"threshold_uncertainty_score":0.02444029,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09002683150155434,"score_gpt":0.3890676012928184,"score_spread":0.299040769791264,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}